RTW

Powering breakthrough therapies
Watch: Our approach to science

01 Our team

Our team guides tomorrow’s most exciting and disruptive companies

Doctors, academics, and drug developers. Seasoned venture capitalists and investment bankers. Experienced lawyers, data scientists, and company operators. We all work as one team. Applying our collective power to build successful companies around brilliant ideas.

02 Our companies

Artiva White C4 White Dermtech White Encoded Therapeutics White Jixing White Artiva White C4 White Dermtech White Encoded Therapeutics White Established Labs White Jixing White Stoke Therapeutics White Tarsus White Ventyx Biosciences White Visus Therapeutics White Frequency White Regenxbio White

Supporting scientists and entrepreneurs to identify opportunity for our companies

As full lifecycle investors, we partner with companies at all stages of development. From a molecule in the hands of one of our scientists to an early-stage entrepreneur with a small team progressing toward the clinic. A pre-IPO clinical stage organization to a multi-product public company. Our partnership goes beyond a check. We put everything we are behind our partners to support their success. Long term. Together.

03 RTW Biotech Opportunities

Shaping the future of life sciences with transformative investments

Identifying and developing the next generation of transformative companies that aim to significantly improve patients' lives. We apply deep scientific expertise with a long-term investment horizon.

04 Our story

Innovation investors, science leaders and company creators. This is our story

RTW is a life science investment and innovation firm. Through our capital and expertise we’re powering breakthroughs in biotech and medtech that will transform the wellbeing of people around the world.

Video

Our purpose

What we do goes beyond short term financial gain. We invest for the long term, powering the next generation of breakthroughs in science and medicine to help transform lives. That’s really what drives us – the greater impact we can help create.

Latest

Ditching delay: GH001’s instant impact on depression

Ditching delay: GH001’s instant impact on depression

Changing minds: Psychedelics as legitimate medicine

Changing minds: Psychedelics as legitimate medicine

Inside the clinic: GLP-1s with Dr. Rekha B. Kumar

Inside the clinic: GLP-1s with Dr. Rekha B. Kumar

The $1 trillion GLP-1 revolution with Rod Wong

The $1 trillion GLP-1 revolution with Rod Wong

RTW Bio Investor Day 2024: Obesity Deep Dive

RTW Bio Investor Day 2024: Fireside Chat with Rod Wong & Baroness Nicola Blackwood

RTW Bio Investor Day 2024: Full Life Cycle Investing Panel Discussion

RTW Bio marks its 5th anniversary since listing on the London Stock Exchange

RTW Bio marks its 5th anniversary since listing on the London Stock Exchange

Careers at RTW

We’re passionate about transforming the lives of patients. Each of us contributes something unique and important to this mission. A shared set of values is what brings us together. Progress. Collaboration. Leadership. Rigor. Tenacity. Humility. These are the things that shape our culture and how we turn our passion into impact. For investors. For patients. And for each other.

Improving the health of underserved communities
RTW Foundation

Speak to a member of our team

This website is not intended to offer or to promote the offer or sale of the shares (the “Shares”) of RTW Biotech Opportunities Ltd (the “Company”) in the United States or to any “U.S. persons” as defined in Regulation S (“US persons”) under the US Securities Act of 1933, as amended (the “Securities Act”). The materials contained herein are not for release, publication or distribution, directly or indirectly, in whole or in part, to any persons to whom or into or within any jurisdiction where to do so would constitute a violation of applicable law or regulation.

The information contained herein and on the pages that follow does not constitute or form a part of any offer to sell or issue, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities in the United States or in any jurisdiction in which, or to any person to whom, such an offer or solicitation would be unlawful.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the “Investment Company Act”), and as such holders of the Shares are not and will not be entitled to the benefits of the Investment Company Act. The Shares have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered, sold, resold, pledged, delivered, assigned or otherwise transferred, directly or indirectly, into or within the United States or to, or for the account or benefit of, any US Persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not result in the Company being required to register under the Investment Company Act. There has been and will be no public offer of the Shares in the United States. The offer and sale of the Shares have not been and will not be registered under the applicable securities laws of Australia, Canada, Japan or South Africa. Potential users of the information contained herein and on the pages that follow are requested to inform themselves about and to observe all applicable restrictions.

The information contained herein and on the pages that follow may contain forward-looking statements. Any statement other than a statement of historical fact is a forward-looking statement. Actual results may differ materially from those expressed or implied by any forward-looking statement. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. You should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance. The Company may change these terms and conditions from time to time and any such changes will be posted on this website. Your access to this website is governed by the version of these terms and conditions then in force.

By clicking “Agree” below, you represent, warrant, undertake and agree that (1) you have read, understood and agree to be bound by the terms and conditions and other information set out herein, (2) you are permitted under applicable laws and regulations to receive the information contained herein and on the pages that follow, (3) you are either (a) located outside the United States and are not a US Person or (b) an existing shareholder of the Company who is a “qualified purchaser” as defined under the Investment Company Act and (4) you will not further transmit or send any information contained in this website to any other persons in the United States, to US Persons, or to any publications with a general circulation in the United States. If you cannot so represent, warrant, undertake and agree, you must click the button labelled “Decline” or otherwise exit this website.

You must accept preferences cookies and refresh your browser to view this video.

Alternatively, if cookies are being blocked by the browser, or you wish to view the video at its source, you can do so by visiting the link below: